APA (7th ed.) Citation

A, W., B, B., E, M., A, W., D, L., BA, L., & P, S. (2021). Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(11), 3106. https://doi.org/10.1158/1078-0432.CCR-20-4315

Chicago Style (17th ed.) Citation

A, Wozniak, Boeckx B, Modave E, Weaver A, Lambrechts D, Littlefield BA, and Schöffski P. "Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 11 (2021): 3106. https://doi.org/10.1158/1078-0432.CCR-20-4315.

MLA (9th ed.) Citation

A, Wozniak, et al. "Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 11, 2021, p. 3106, https://doi.org/10.1158/1078-0432.CCR-20-4315.